NCT04256044
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- NIHR Leicester Biomedical Research Centre, Glenfield Hospital Leicester, United Kingdom
Clinical trial condition
Hypersensitivity, Immediate
Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.
6,751 public trials
635 recruiting studies
Hypersensitivity, Immediate trial results
Completed
Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients
NCT02555371
- Conditions
- Asthma, Bronchial Diseases, Eosinophilia, +12 more
- Locations
-
- GSK Investigational Site Long Beach, California, United States
- GSK Investigational Site Riverside, California, United States
- GSK Investigational Site Denver, Colorado, United States
- GSK Investigational Site New Haven, Connecticut, United States
NCT02409277
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- University of Utah Salt Lake City, Utah, United States
NCT00129649
- Conditions
- Actinomycetales Infections, Apnea, Asthma, +26 more
- Locations
-
- NHLI Imperial College London, United Kingdom
Completed
Comparison of Vibrating Mesh Nebulizer Versus Jet Nebulizer in the Pediatric Asthma Patient
NCT02774941
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Children's Medical Center Dallas, Texas, United States
NCT03672994
- Conditions
- Asthma, Breathlessness, Bronchial Diseases, +26 more
- Locations
-
- NIHR Leicester Biomedical Research Centre - Respiratory, Glenfield Hospital Leicester, Leicestershire, United Kingdom
NCT02865577
- Conditions
- Asthma, Bronchial Diseases, Chronic Disease, +11 more
- Locations
-
- Glenfield Hospital Leicester, Leicestershire, United Kingdom
NCT03368339
- Conditions
- Allergic Conjunctivitis, Conjunctival Diseases, Conjunctivitis, +5 more
- Locations
-
- Principal Investigator Philadelphia, Pennsylvania, United States
NCT00129987
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- NHLI at Charing Cross Hospital Campus London, United Kingdom
NCT02892019
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Novartis Investigative Site Bruges, Belgium
- Novartis Investigative Site Brussels, Belgium
- Novartis Investigative Site Bogotá, Colombia
- Novartis Investigative Site Bucaramanga, Colombia